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study was to estimate the proportion of cleft palate surgeries identified as secondary 
(or revision) in patients with a diagnosis of cleft palate only or cleft lip and palate. 
Additional objectives included identification and analysis of patient and hospital 
level characteristics. Methods: The Kids’ Inpatient Database (KID), a nationally 
representative sample of pediatric inpatient visits, was used for this study. Years 
analyzed included 2003, 2006, and 2009. Subjects were identified by International 
Classification of Diseases Ninth Revision (ICD-9) diagnosis of cleft palate only or 
cleft lip and palate. Primary surgery was defined as a surgery before three years of 
age with the ICD-9 procedural code ‘Correction Cleft Palate.’ Secondary surgery was 
defined as a surgery at age three or older with any of the following ICD-9 procedural 
codes: ‘Correction Cleft Palate,’ ‘Revision Cleft Palate Repair,’ ‘Closure Fistula Mouth,’ 
or ‘Plastic Repair Palate.’ Hospital, patient, and clinical characteristics were also 
examined across cohorts. All costs were adjusted to 2009 dollars using the Consumer 
Price Index (CPI). Results: For the three years combined, 15,861 discharges for cleft 
palate repair were reported: 7,856 for CP only patients and 8,055 for CLP patients. 
Secondary surgery accounted for 28.1% (N= 2,193) of palate repairs performed in 
children with CP only, compared to 43.5% (N= 3,505) of palate repairs in children 
with CLP. Secondary surgery rates did not differ significantly across years. From 
2003-2009, CPI-adjusted costs decreased in all cohorts except secondary surgery in 
CP only patients. ConClusions: Secondary surgeries represent a significant por-
tion of cleft palate repairs performed in the United States. Children with cleft palate 
only have fewer secondary surgeries compared to those with cleft lip and palate.
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objeCtives: To evaluate prior disease-modifying drug (DMD) use among currently 
treated and currently untreated multiple sclerosis (MS) patients. Methods: A ran-
dom sample of MS patients (age > 18 years) from the National Health and Wellness 
Survey or Lightspeed Research panel completed an internet survey in November/
December 2012. The survey contained questions related to demographics, disease 
characteristics, and current and prior DMD use. The number and percentage of 
patients reporting prior DMD use by current therapy groups (self-injectable DMDs, 
infusion DMDs, oral DMDs, and not currently on DMD) is described. Results: 
There were 969 patients who completed the survey. Average age was 48.8 years (SD 
11.3), 82.9% were female and 737 (76.1%) were currently receiving DMD treatment 
[self-injectable: 576 (78.2%); infusion: 84 (11.4%); oral: 77 (10.4%)]; while 232 (23.9%) 
were currently untreated. Among patients currently treated with a self-injectable 
DMD, most patients were either on their first treatment (57.7%) or had prior use 
of 1 DMD (27.4%). For those currently treated with an infusion DMD, 42.9% had 
prior use of 1 DMD, 36.9% had prior use of 2 DMDs, and 17.9% had prior use of ≥ 3 
DMDs. For patients currently treated with an oral DMD, 27.3% had prior use of 1 
DMD, 32.5% had prior use of 2 DMDs, 32.5% had prior use of ≥ 3 DMDs, and 7.8% 
were initially treated with an oral DMD. For those not currently on a DMD, 34.9% 
were untreated, while 33.2%, 18.5%, and 13.4% had prior use of 1, 2, or ≥ 3 DMDs, 
respectively. ConClusions: In this sample of MS patients, 8.4% had never been 
treated with a DMD. Most patients initiated therapy with a self-injectable DMD, 
while patients currently treated with infusion and oral DMDs had prior use of 1 
or more DMDs.
research Poster PreseNtatioNs - sessioN ii
Disease-sPecific stuDies 
caNcer – clinical outcomes studies
PcN1
Meta-aNalysis of aNastoMotic leak rates folloWiNg haND-seWN 
suture Versus staPleD aNastoMoses DuriNg right coloN surgery
Roy S.1, Ghosh S.K.2, Aggarwal S.3, Yoo A.C.2
1Ethicon Surgical Care, Johnson & Johnson, Somerville, NJ, USA, 2Ethicon Surgical Care, Johnson & 
Johnson, Cincinnati, OH, USA, 3Novel Health Strategies, Bethesda, MD
objeCtives: Ileocolic anastomoses are commonly performed for right-sided colon 
cancer and Crohn’s disease. Anastomotic leak complications are a significant source 
of patient morbidity and mortality and have a major impact on health care costs. 
The objective of this analysis was to compare anastomotic leak rates following 
ileocolic anastomoses performed using mechanical stapling and hand-sewn suture 
techniques. Methods: Pubmed, Embase, Cochrane Library and trial registries were 
searched for randomized controlled trials comparing hand-sewn and stapled ile-
ocolic anastomoses published between 1990 and December 2013. The odds ratio (OR) 
for overall anastomotic leak rate was calculated and then weighted and pooled in a 
meta-analysis with Mantel-Haenszel fixed-effect modeling with Chi square test for 
heterogeneity. Results: Eight studies with a total of 1,172 patients were included. 
Two studies were from Germany, 2 from Scotland, 1 from France, 1 from Japan, 1 from 
US and 1 was a global study with patients from US, UK and Canada. The median and 
average sample sizes across studies were 112 and 149 patients, respectively. Three 
studies were for Crohn’s disease, 3 were for colorectal cancer and 2 were for other 
diagnoses. There were 11 (2.31%) anastomotic leaks reported in 457 patients in the 
mechanically stapled group, and 44 (6.15%) leaks in 715 patients in the hand-sewn 
(sutures) group. At study level, the median leak rates in stapled and hand-sewn 
groups were 0.40% and 3.95%, respectively. Overall, the odds of anastomotic leaks 
were reduced to less than half with mechanical stapling compared to hand sewn 
techniques (pooled OR = 0.46; 95% CI = 0.24 to 0.89; p = 0.02). ConClusions: This 
meta-analysis of randomized controlled trials comparing hand-sewn with stapled 
ileocolic anastomoses demonstrates a significantly lower rate of anastomotic leak-
gery at age two or older with the ICD-9 procedural code for cleft lip repair. Additional 
characteristics examined across cohorts include length of stay and Consumer Price 
Index (CPI) adjusted charges. Results: A total of 8,385 discharges for cleft lip repair 
were reported. In CL patients secondary surgery represented 16.3% (N= 134), 14.2% 
(N= 105), and 15.1% (N= 129) of surgeries for 2003, 2006, and 2009, respectively. In CLP 
patients secondary surgery represented 25.7% (N= 511), 25.2% (N= 506), and 28.2% 
(N= 555) for 2003, 2006, and 2009, respectively. From 2003-2009, mean length of stay 
and CPI-adjusted costs decreased in all cohorts except secondary surgery in CL 
patients. ConClusions: One fourth of all children required secondary surgery. 
The proportion of secondary cleft lip surgery did not differ significantly across 
years. Once adjusted, costs have decreased for the majority of patients, a finding 
in contrast to previously published studies.
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objeCtives: This study investigated the effect of Medicare Part D on prescribing 
patterns and drug utilization of non-benzodiazepine sedative hypnotics. Methods: 
Time-series analyses were conducted using data from National Ambulatory Medical 
Care Survey (NAMCS). Subjects were derived from US. outpatient visits between 2002 
and 2009 where the primary payment source was Medicare and at least one non-
benzodiazepine sedative hypnotic drug was prescribed. Data trends were graphically 
plotted and further analyzed using segmented regression to estimate the effects of 
the Medicare Part D on drug utilization. A weighted multivariate logistic regression 
was conducted to predict the maximum likelihood of prescribing pattern associated 
with patient and physician socioeconomic characteristics. All analyses utilized SAS 
PROC SURVEY applications to adjust for the complex sampling design employed 
by NAMCS database. Results: An estimated 31.52 million of Medicare beneficiar-
ies received at least one non-benzodiazepine prescription between 2002 and 2009 
during their outpatient visits. After Medicare part D in 2006, there was a notable 
increase (24%) in Medicare outpatient visits between 2006 and 2009. In the same 
time period, prescribing of non-benzodiazepine sedatives increased significantly 
by 46.3%. The results from segmented regression indicate that the implementation 
of Medicare Part D drug benefits has significantly increased the sedative utiliza-
tion in Medicare population (P= 0.0001). Multivariate logistic regression revealed 
that patient gender, geography, chronic condition, and physician specialty all play 
an important role in determining the utilization pattern of non-benzodiazepine 
sedatives. ConClusions: Our study indicated that the use of non-benzodiazepine 
hypnotics increased dramatically after Medicare Part D. Increased utilization may 
also be related to the switching effect from benzodiazepine formulary exclusion 
and/or antidepressant off-label use for insomnia pharmacotherapy. These findings 
show the importance of using data analysis to identify substantial consequences 
from policy implementation and the need to provide additional guidance to insurers 
on how to effectively monitor prescribing patterns.
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objeCtives: To evaluate the burden of 30-day readmissions in adjunctively-treated 
patients with epilepsy. Methods: The MarketScan®retrospective database (Jan-
2006 to Dec-2011) was used. Selected patients had: ≥ 1 diagnosis code for epilepsy 
(ICD-9 345.xx), age ≥ 18, ≥ 1 hospitalization (index), and received adjunctive AEDs 
during study period. Eligible patients had 60 days pre- and ≥ 365 days post-index 
continuous enrolment. Patients were stratified by type of hospitalization (all-cause 
or epilepsy-related) and by partial vs. generalized epilepsy diagnosis. Readmissions 
were defined as any hospitalization occurring < 30 days from the preceding hospi-
talization’s discharge date. Results: Of a total of 504,507 patients, 141,017 (19%; age 
51±17.6; 59% female, average follow-up 1,188 days) had ≥ 1 all-cause hospitalizations, 
and of these, 91,587 (65%) had an epilepsy-related admission, and 41,453 (29%) had 
≥ 1 all-cause 30-day readmissions. Forty-six percent of patients (8,955) had epilepsy-
related readmissions. Among patients with epilepsy-related hospitalizations, 19,115 
(21%) had ≥ 1 all-cause 30-day readmissions, 61% of whom (11,670) had epilepsy-
related readmissions. Partial epilepsy accounted for 9,882 (7%) of the total number 
of patients hospitalized (all-cause) during the study period; 100% of these patients 
had one or more epilepsy-related admissions. Among the hospitalized (all-cause) 
with POS, 1,729 (18%) had ≥ 1 all-cause readmissions, and of these 1,140 (66%) had ≥ 1 
epilepsy-related readmissions. Among POS patients with epilepsy-related hospitali-
zations, 1,502 (15%) had ≥ 1 all-cause readmissions, and of these 1,055 (70%) had ≥ 1 
epilepsy-related readmissions. ConClusions: In this study, approximately one in 
three patients with epilepsy hospitalized for any reason had a 30-day readmission, 
with approximately half of these patients presenting 30-day readmissions due to 
epilepsy. Approximately 60% of patients with an epilepsy-related admission had 
a 30-day readmission due to epilepsy. Patients with partial epilepsy had a greater 
burden of epilepsy-related hospitalizations and readmissions.
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objeCtives: Children with cleft palate (CP) or cleft lip and palate (CLP) may require 
multiple surgeries to improve their appearance and function. The objective of this 
